Calcium Alpha-
Ketoglutarate
The Krebs cycle metabolite that declines with age and may support cellular energy, muscle health, and biological aging pathways.
Calcium alpha-ketoglutarate (Ca-AKG) is a stabilized form of alpha-ketoglutarate, a key intermediate in the tricarboxylic acid cycle. Due to poor oral bioavailability of free AKG, the calcium salt enhances absorption while providing dual metabolic and mineral benefits. Emerging research suggests potential roles in cellular energy production, muscle preservation, bone health, and aging-related pathways.
Strong preclinical evidence and emerging moderate human trial data support AKG/CaAKG for biological aging (DNA methylation), muscle health, bone health, and cardiovascular function. Multiple animal models show lifespan extension and healthspan improvements. Human RCT evidence is limited but growing (ABLE trial, aging-related interventions, kidney disease in hemodialysis patients documented as possibly effective by WebMD). Athletic performance shows mixed results depending on dosage, population, and training context. Brain/Alzheimer's neuroprotection and reproductive aging benefits have strong mechanistic and preliminary animal evidence but very limited human data. Sustained-release CaAKG formulations supported by bioavailability research and user experience but limited head-to-head comparative trials. Overall category: Moderate, reflecting solid mechanistic understanding, promising but limited human trials, and strong animal/in vitro support.
Biological Age and Longevity (DNA Methylation)
ModerateMultiple studies using DNA methylation clocks show CaAKG supplementation reduces biological age. A retrospective analysis of 42 individuals taking sustained-release CaAKG for 7 months showed an average 8-year reduction in biological age (p=6.538×10⁻¹²). A randomized controlled trial in healthy adults with baseline epigenetic age acceleration showed significant reductions in epigenetic age (p=0.015) using a multi-nutrient formula containing AKG. These effects appear mediated through DNA methylation pathways and may indicate slowing of aging-related processes.
Muscle Health and Atrophy Prevention
ModerateAKG reduces muscle protein degradation and increases muscle strength and endurance. A study of 35 resistance-trained men taking 12 g/day AAKG for 8 weeks showed increased muscle strength and endurance with reduced protein degradation. Untrained men on 0.2 g/kg/day for 4 weeks increased training volume, maximum power output, and muscle torque. Co-supplementation with β-hydroxy-β-methylbutyrate prevented decline in jump performance in young athletes. AKG acts as a precursor to amino acids (particularly proline and glutamine for collagen) and supports protein synthesis while inhibiting degradation.
Exercise Performance and Recovery
ModerateAKG supplementation has enhanced endurance, reduced fatigue, and supported faster post-exercise recovery in multiple studies. For untrained men, it increased training volume and maximum power output. Soccer players aged 14-15 showed improved maximal and lactate threshold running speeds after intensified training with 5-HMF/AKG combination. However, results are mixed in some athletic populations; one study found no significant effect on short-term maximal power output in well-trained cyclists. Effects appear most pronounced in endurance and moderate-intensity exercise rather than maximal efforts.
Bone Health and Density
LimitedA clinical study found that AKG reduced serum C-terminal cross-linked type I collagen (CTX) and promoted osteocalcin expression in postmenopausal women, with significant increases in spinal bone density. AKG promotes osteoblast differentiation and increases alkaline phosphatase (ALP), type I collagen, osteopontin, and osteocalcin. In animal models, AKG-enriched fibrin enhanced rotator cuff tendon-to-bone healing in osteoporotic rats by improving bone quality and increasing osteoblastic activity. An active clinical trial (NCT07114536) is measuring bone calcium content changes with CaAKG supplementation.
Cardiovascular and Heart Function
LimitedAKG supplementation improved cardiac function in mice with pressure overload-induced heart failure. At 6 weeks after transverse aortic constriction, AKG-treated mice showed 49.11% decrease in cardiomyocyte cross-sectional area and improved left ventricular fractional shortening and ejection fraction compared to untreated mice (p<0.001). AKG reduced myocardial reactive oxygen species (ROS) production, reduced cardiomyocyte apoptosis, and repaired Ang II-mediated injury to mitochondrial membrane potential. These effects suggest potential benefits in heart failure prevention and post-exercise cardiac recovery.
Kidney Function and Chronic Kidney Disease
LimitedAdministration of calcium-AKG in chronic renal failure patients undergoing hemodialysis improved kidney functions, including increased plasma concentrations of arginine, proline, and histidine, as well as decreased inorganic phosphate and urea. AKG regulates acid-base balance in renal tubules and maintains nitrogen and protein balance. Animal models show AKG attenuates lipopolysaccharide-induced acute kidney injury by counteracting oxidative stress and improving energy metabolism. WebMD lists CKD as 'possibly effective' based on lab test improvements in hemodialysis patients.
Brain Health and Alzheimer's Disease Prevention
LimitedRecent research shows CaAKG ameliorates long-term potentiation (LTP) deficits in Alzheimer's disease models (APP/PS1 mice), with more profound effects in female mice than males. CaAKG restored synaptic tagging and capture, a mechanism for associative memory formation. Treatment increased autophagy markers and acted through NMDA receptor-independent pathways involving L-type calcium channels and calcium-permeable AMPA receptors. These findings suggest CaAKG may support memory processes disrupted in Alzheimer's and delay cognitive aging. Effects appear mediated by mTOR pathway suppression and mitochondrial function enhancement.
Wound Healing and Post-Surgical Recovery
LimitedAKG-enriched polymeric microparticles demonstrated faster wound closure in mice (wounds closed by day 9 vs. later in controls) with increased collagen type III deposition and higher ultimate tensile strength. Sustained-release AKG was superior to bolus delivery, suggesting inflammatory phase timing matters. AKG reduces wound healing time, increases collagen synthesis, and promotes rapid tissue regeneration. Historical use in athletes for muscle recovery extends to post-operative settings where it supported faster recovery from surgery or trauma.
Inflammation and Immune Function
ModerateAKG suppresses NF-κB-mediated inflammatory pathways and normalizes plasma concentrations of TNF-α and IL-1β following lipopolysaccharide challenge. In intestinal inflammation models, AKG increased mRNA expression of defensins (cryptdins) and modulated the intestinal microbiota, favoring Bacteroidetes over Firmicutes. It increases anti-inflammatory IL-10 while reducing pro-inflammatory markers. AKG's anti-inflammatory effects involve activation of the PXR pathway and enhancement of TCA cycle enzyme activity, supporting energy metabolism concurrent with immune modulation.
Body Weight and Metabolic Health
LimitedAKG supplementation lowered body weight gain rate in mice (p<0.05) while increasing feed intake, suggesting improved lipolysis and fatty acid oxidation. The weight loss effect was mediated by intestinal microbiota changes (increase in Bacteroidetes ratio), as shown when antibiotic-treated germ-free mice did not respond. AKG may improve body composition by enhancing NO and Arg synthesis, promoting fat oxidation over deposition. However, human studies on weight loss are limited; this benefit is primarily demonstrated in animal models.
Bone-Tendon Healing (Rotator Cuff)
LimitedLocal supplementation of αKG-enriched fibrin enhanced rotator cuff tendon-to-bone healing in postmenopausal osteoporotic rats. AKG improved bone quality (higher bone volume/total volume, trabecular number and thickness) and tendon-bone resilience (higher ultimate failure load and stress). Effects were mediated by decreased osteoclastic activity and increased osteoblastic activity. This suggests clinical application potential for preventing anchor pullout and improving rotator cuff tear outcomes in patients with osteoporosis complications.
Reproductive Health and Fertility
LimitedLong-term AKG administration in aged mice (14 months) preserved ovarian function and delayed reproductive decline. Treated mice maintained 8-9 pups/litter compared to control's 6-7, with significantly improved mating and pregnancy rates (p<0.05). AKG reduced telomere shortening in ovaries, upregulated telomerase (TERT, TERC) and SIRT6 expression, and downregulated mTOR pathway. In oocytes, AKG improves quality and quantity while reducing oxidative stress. However, human studies are extremely limited; findings are primarily in animal models of reproductive aging.
Hair Growth and Follicle Development
LimitedAKG supplementation significantly increased hair follicle density in animal studies. At 6 mmol/L in vitro and 1.5% dietary dose in vivo, AKG promoted dermal papilla cell proliferation, increased hair follicle density (primary and secondary), and enhanced antioxidant capacity in skin tissue. Effects are mediated through Wnt signaling pathway activation (upregulation of Wnt10b and β-catenin) and increased amino acid availability (glutamine, glutamic acid). AKG activated autophagy in follicle cells and promoted hair regeneration by targeting mTOR signaling.
Antioxidant and Oxidative Stress Protection
ModerateAKG directly scavenges hydrogen peroxide through nonenzymatic oxidative decarboxylation, producing succinate, water, and CO₂. It enhances antioxidant enzyme activities (SOD, catalase, GPx) and maintains glutathione (GSH) levels, protecting against ammonia, cyanide, and ROS-induced damage. In neuronal models, AKG attenuates H₂O₂-induced senescence by reducing ROS, restoring mitochondrial function, and downregulating p53/p21 senescence markers. These effects contribute to protection against oxidative stress in brain, kidney, liver, and other organs.
Intestinal Health and Barrier Function
LimitedAKG supplementation maintains intestinal epithelial integrity and reduces damage to intestinal epithelial cells. Following bariatric surgery in rats, AKG improved tight junction protein expression, increased villi height and crypt depth, enhanced mucosal thickness, and improved innervation. It promoted expression of mammalian defensins (cryptdins) supporting intestinal innate immunity. These effects suggest benefit for post-surgical intestinal recovery, inflammatory bowel conditions, and intestinal barrier dysfunction characterized by increased permeability.
Liver Function and Ammonia Detoxification
LimitedAKG lowers ammonia levels in the body and maintains nitrogen and protein balance by enhancing ureagenesis and ammonia detoxification. In hepatic encephalopathy models, AKG (as L-ornithine L-aspartate/LOLA) reduces blood ammonia and improves hepatic encephalopathy grade. It supports glutamine synthesis and protein anabolic effects in skeletal muscle, reducing systemic nitrogen load. This mechanism is particularly relevant in chronic liver disease and hepatic encephalopathy where ammonia accumulation causes neurotoxicity.
Osteoarthritis and Joint Health
LimitedAKG supplementation enhanced chondrocyte proliferation and extracellular matrix accumulation in cartilage models. It reduced oxidative damage and increased ECM production in IL-1β-treated chondrocytes. In OA mouse models, intra-articular AKG injection reduced cartilage degradation and improved histological scores. AKG activates TET enzymes promoting DNA demethylation of cartilage matrix genes (COL2A1, ACAN), reduces inflammatory cytokine expression (IL-6/JAK2/STAT3), and decreases ferroptosis-related markers. Effects support cartilage preservation and joint structural integrity.
Stem Cell Function and Differentiation
LimitedIncreased intracellular AKG accelerated initial differentiation of primed human pluripotent stem cells (hPSCs) and epiblast stem cells (EpiSCs). AKG-to-succinate ratio elevation promoted both histone and DNA demethylation in primed PSCs, suggesting epigenetic regulation of stem cell fate. This mechanism connects AKG to pluripotency gene expression modulation and differentiation dynamics, with implications for developmental biology and potential regenerative medicine applications, though human clinical applications remain experimental.
Son güncelleme: